Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'HOLST JJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 308 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Rasmussen, TN; Schmidt, P; Poulsen, SS; Holst, JJ
      Effect of calcitonin gene-related peptide (CGRP) on motility and on the release of substance P, neurokinin A, somatostatin and gastrin in the isolated perfused porcine antrum

      NEUROGASTROENTEROLOGY AND MOTILITY
    2. Verdich, C; Toubro, S; Buemann, B; Holst, JJ; Bulow, J; Simonsen, L; Sondergaard, SB; Christensen, NJ; Astrup, A
      Leptin levels are associated with fat oxidation and dietary-induced weightloss in obesity

      OBESITY RESEARCH
    3. Ronnblom, A; Hellstrom, PM; Holst, JJ; Theodorsson, E; Danielsson, A
      Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy

      EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
    4. Gutniak, MK; Svartberg, J; Hellstrom, PM; Holst, JJ; Adner, N; Ahren, B
      Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes

      JOURNAL OF INTERNAL MEDICINE
    5. Vilsboll, T; Krarup, T; Madsbad, S; Holst, JJ
      No reactive hypoglycaemia in Type 2 diabetic patients after subcutaneous administration of GLP-1 and intravenous glucose

      DIABETIC MEDICINE
    6. Knudsen, LB; Agerso, H; Bjenning, C; Bregenholt, S; Carr, RD; Godtfredsen, C; Holst, JJ; Huusfeldt, PO; Larsen, MO; Larsen, PJ; Nielsen, PF; Ribel, U; Rolin, B; Romer, J; Sturis, J; Wilken, M; Kristensen, P
      GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development

      DRUGS OF THE FUTURE
    7. Verdich, C; Toubro, S; Buemann, B; Madsen, JL; Holst, JJ; Astrup, A
      The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction

      INTERNATIONAL JOURNAL OF OBESITY
    8. Flint, A; Raben, A; Ersboll, AK; Holst, JJ; Astrup, A
      The effect of physiological levels of glucagon-like peptide-1 on appetite,gastric emptying, energy and substrate metabolism in obesity

      INTERNATIONAL JOURNAL OF OBESITY
    9. Enc, FY; Imeryuz, N; Akin, L; Turoglu, T; Dede, F; Haklar, G; Tekesin, N; Bekiroglu, N; Yegen, BC; Rehfeld, JF; Holst, JJ; Ulusoy, NB
      Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    10. Ljungmann, K; Hartmann, B; Kissmeyer-Nielsen, P; Flyvbjerg, A; Holst, JJ; Laurberg, S
      Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    11. Hojlund, K; Wildner-Christensen, M; Eshoj, O; Skjaerbaek, C; Holst, JJ; Koldkjaer, O; Jensen, DM; Beck-Nielsen, H
      Reference intervals for glucose, beta-cell polypeptides, and counterregulatory factors during prolonged fasting

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    12. Rasmussen, TN; Schmidt, P; Poulsen, SS; Holst, JJ
      Localisation and neural control of the release of calcitonin gene-related peptide (CGRP) from the isolated perfused porcine ileum

      REGULATORY PEPTIDES
    13. Tornoe, K; Hannibal, J; Georg, B; Schmidt, PT; Hilsted, L; Fahrenkrug, J; Holst, JJ
      PACAP 1-38 as neurotransmitter in the porcine antrum

      REGULATORY PEPTIDES
    14. Gebhard, B; Holst, JJ; Biegelmayer, C; Miholic, J
      Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome

      DIGESTIVE DISEASES AND SCIENCES
    15. Thulesen, J; Hartman, B; Kissow, H; Jeppsen, PK; Orskov, C; Holst, JJ; Poulsen, SS
      Intestinal growth adaptation and glucagon-like peptide 2 in rats with ileal-jejunal transposition or small bowel resection

      DIGESTIVE DISEASES AND SCIENCES
    16. Rask, E; Olsson, T; Soderberg, S; Johnson, O; Seckl, J; Holst, JJ; Ahren, B
      Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men

      DIABETES CARE
    17. Zander, M; Taskiran, M; Toft-Nielsen, MB; Madsbad, S; Holst, JJ
      Additive glucose-lowering effects of glucagon-like peptide-1 and metforminin type 2 diabetes

      DIABETES CARE
    18. Naslund, E; Bogefors, J; Gryback, P; Bjellerup, P; Jacobsson, H; Holst, JJ; Hellstrom, PM
      GLP-1 inhibits gastric emptying of water but does not influence plasma vasopressin, sodium, or osmolality

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    19. Holst, JJ; Orskov, C
      Incretin hormones - an update

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    20. van Goudoever, JB; Stoll, B; Hartmann, B; Holst, JJ; Reeds, PJ; Burrin, DG
      Secretion of trophic gut peptides is not different in bolus- and continuously fed piglets

      JOURNAL OF NUTRITION
    21. Friis-Hansen, L; Lacourse, KA; Samuelson, LC; Holst, JJ
      Attenuated processing of proglucagon and glucagon-like peptide-1 in carboxypeptidase E-deficient mice

      JOURNAL OF ENDOCRINOLOGY
    22. Verdich, C; Flint, A; Gutzwiller, JP; Naslund, E; Beglinger, C; Hellstrom, PM; Long, SJ; Morgan, LM; Holst, JJ; Astrup, A
      A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    23. Toft-Nielsen, MB; Damholt, MB; Madsbad, S; Hilsted, LM; Hughes, TE; Michelsen, BK; Holst, JJ
      Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    24. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
      Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    25. Jeppesen, PB; Hartmann, B; Thulesen, J; Graff, J; Lohmann, J; Hansen, BS; Tofteng, F; Poulsen, SS; Madsen, JL; Holst, JJ; Mortensen, PB
      Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon

      GASTROENTEROLOGY
    26. Deacon, CF; Danielson, P; Klarskov, L; Olesen, M; Holst, JJ
      Dipeptidyl peptidase IV inhibition reduces the degradation and clearance of GIP and potentiates its insulinotropic and antihyperglycemic effects in anesthetized pigs

      DIABETES
    27. Staehr, P; Hother-Nielsen, O; Levin, K; Holst, JJ; Beck-Nielsen, H
      Assessment of hepatic insulin action in obese type 2 diabetic patients

      DIABETES
    28. Ahren, B; Holst, JJ
      The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia

      DIABETES
    29. Ritzel, R; Schulte, M; Porksen, N; Nauck, MS; Holst, JJ; Juhl, C; Marz, W; Schmitz, O; Schmiegel, WH; Nauck, MA
      Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance

      DIABETES
    30. Vella, A; Shah, P; Basu, R; Basu, A; Camilleri, M; Schwenk, FW; Holst, JJ; Rizza, RA
      Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes

      DIABETES
    31. Vilsboll, T; Krarup, T; Deacon, CF; Madsbad, S; Holst, JJ
      Reduced postprandial concentrations of intact biologically active gluccagon-like peptide 1 in type 2 diabetic patients

      DIABETES
    32. Meier, JJ; Huking, K; Holst, JJ; Deacon, CF; Schmiegel, WH; Nauck, MA
      Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

      DIABETES
    33. Raben, A; Holst, JJ; Madsen, J; Astrup, A
      Diurnal metabolic profiles after 14 d of an ad libitum high-starch, high-sucrose, or high-fat diet in normal weight never-obese and postobese women

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    34. Schmidt, PT; Holst, JJ
      Tachykinins in regulation of gastric motility and secretion

      CELLULAR AND MOLECULAR LIFE SCIENCES
    35. Schmidt, PT; Tornoe, K; Poulsen, SS; Rasmussen, TN; Holst, JJ
      Tachykinins in the porcine pancreas: Potent exocrine and endocrine effectsvia NK-1 receptors

      PANCREAS
    36. Hedetoft, C; Sheikh, SP; Larsen, S; Holst, JJ
      Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitis

      PANCREAS
    37. Jorgensen, TOL; Rosenfalck, AM; Fisker, S; Nyholm, B; Fineman, MS; Schmitz, O; Madsbad, S; Holst, JJ; Christiansen, JS
      Circulating levels of incretin hormones and amylin in the fasting state and after oral glucose in GH-deficient patients before and after GH replacement: a placebo-controlled study

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    38. Juntti-Berggren, L; Pigon, J; Hellstrom, P; Holst, JJ; Efendic, S
      Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes

      DIABETES NUTRITION & METABOLISM
    39. Filipsson, K; Holst, JJ; Ahren, B
      PACAP contributes to insulin secretion after gastric glucose gavage in mice

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    40. Verdich, C; Madsen, JL; Toubro, S; Buemann, B; Holst, JJ; Astrup, A
      Effect of obesity and major weight reduction on gastric emptying

      INTERNATIONAL JOURNAL OF OBESITY
    41. Flint, A; Raben, A; Rehfeld, JF; Holst, JJ; Astrup, A
      The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans

      INTERNATIONAL JOURNAL OF OBESITY
    42. Thulesen, J; Hartmann, B; Orskov, C; Jeppesen, PB; Holst, JJ; Poulsen, SS
      Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected I-125-GLP-2

      PEPTIDES
    43. Hartmann, B; Johnsen, AH; Orskov, C; Adelhorst, K; Thim, L; Holst, JJ
      Structure, measurement, and secretion of human glucagon-like peptide-2

      PEPTIDES
    44. Burrin, DG; Stoll, B; Jiang, R; Petersen, Y; Elnif, J; Buddington, RK; Schmidt, M; Holst, JJ; Hartmann, B; Sangild, PT
      GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosis

      AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
    45. Tornoe, K; Hannibal, J; Jensen, TB; Georg, B; Rickelt, LF; Andreasen, MB; Fahrenkrug, J; Holst, JJ
      PACAP-(1-38) as neurotransmitter in the porcine adrenal glands

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    46. Hansen, L; Hartmann, B; Bisgaard, T; Mineo, H; Jorgensen, PN; Holst, JJ
      Somatostatin restrains the secretion of glucagon-like peptide-1 and-2 fromisolated perfused porcine ileum

      AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    47. Holst, JJ
      Gut hormones as pharmaceuticals. From enteroglucagon to GLP-1 and GLP-2

      REGULATORY PEPTIDES
    48. Vilsboll, T; Toft-Nielsen, MB; Krarup, T; Madsbad, S; Dinesen, B; Holst, JJ
      Evaluation of beta-cell secretory capacity using glucagon-like peptide 1

      DIABETES CARE
    49. Henriksen, JH; Holst, JJ; Moller, S; Andersen, UB; Bendtsen, F; Jensen, G
      Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin

      CLINICAL SCIENCE
    50. Schmidt, PT; Hartmann, B; Bregenholt, S; Holst, JJ; Claesson, MH
      Deficiency of the intestinal growth factor, glucagon-like peptide 2, in the colon of SCID mice with inflammatory bowel disease induced by transplantation of CD4+T cells

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    51. Buemann, B; Toubro, S; Holst, JJ; Rehfeld, JF; Bibby, BM; Astrup, A
      D-tagatose, a stereoisomer of d-fructose, increases blood uric acid concentration

      METABOLISM-CLINICAL AND EXPERIMENTAL
    52. Poulsen, PL; Orskov, L; Grofte, T; Moller, J; Holst, JJ; Schmitz, O; Moller, N
      Effects of oral glucose on systemic glucose metabolism during hyperinsulinemic hypoglycemia in normal man

      METABOLISM-CLINICAL AND EXPERIMENTAL
    53. Hartmann, B; Harr, MB; Jeppesen, PB; Wojdemann, M; Deacon, CF; Mortensen, PB; Holst, JJ
      In vivo and in vitro degradation of glucagon-like peptide-2 in humans

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    54. Ahren, B; Holst, JJ; Efendic, S
      Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    55. Deacon, CF; Nauck, MA; Meier, J; Hucking, K; Holst, JJ
      Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    56. Jeppesen, PB; Hartmann, B; Thulesen, J; Hansen, BS; Holst, JJ; Poulsen, SS; Mortensen, PB
      Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon

      GUT
    57. Ahren, B; Holst, JJ; Martensson, H; Balkan, B
      Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    58. Ahren, B; Holst, JJ; Yu, SK
      1,5-anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice

      EUROPEAN JOURNAL OF PHARMACOLOGY
    59. Hartmann, B; Thulesen, J; Kissow, H; Thulesen, S; Orskov, C; Ropke, C; Poulsen, SS; Holst, JJ
      Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect ofglucagon-like peptide-2 rats and mice

      ENDOCRINOLOGY
    60. Juhl, CB; Schmitz, O; Pincus, S; Holst, JJ; Veldhuis, J; Porksen, N
      Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness

      DIABETOLOGIA
    61. Henriksen, JE; Levin, K; Thye-Ronn, P; Alford, F; Hother-Nielsen, O; Holst, JJ; Beck-Nielsen, H
      Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients

      DIABETES
    62. Vella, A; Shah, P; Basu, R; Basu, A; Holst, JJ; Rizza, RA
      Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness andinsulin action in people with type 2 diabetes

      DIABETES
    63. Burrin, DG; Stoll, B; Jiang, RH; Chang, XY; Hartmann, B; Holst, JJ; Greeley, GH; Reeds, PJ
      Minimal enteral nutrient requirements for intestinal growth in neonatal piglets: how much is enough?

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    64. Madsen, P; Brand, CL; Holst, JJ; Knudsen, LB
      Advances in non-peptide glucagon receptor antagonists

      CURRENT PHARMACEUTICAL DESIGN
    65. Holst, JJ
      Glucagon-like peptide 1 (GLP-1): An intestinal hormone, signalling nutritional abundance, with an unusual therapeutic potential

      TRENDS IN ENDOCRINOLOGY AND METABOLISM
    66. Tang-Christensen, M; Holst, JJ; Hartmann, B; Vrang, N
      The arcuate nucleus is pivotal in mediating the anorectic effects of centrally administered leptin

      NEUROREPORT
    67. Holst, JJ
      Glucagon-like peptide-1, a gastrointestinal hormone with a pharmaceutical potential

      CURRENT MEDICINAL CHEMISTRY
    68. Plockinger, U; Holst, JJ; Messerschmidt, D; Hopfenmuller, W; Quabbe, HJ
      Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

      EUROPEAN JOURNAL OF ENDOCRINOLOGY
    69. Naslund, E; Bogefors, J; Skogar, S; Gryback, P; Jacobsson, H; Holst, JJ; Hellstrom, PM
      GLP-1 slows solid gastric emptying and inhibits insulin, glucagon, and PYYrelease in humans

      AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    70. Naslund, E; Barkeling, B; King, N; Gutniak, M; Blundell, JE; Holst, JJ; Rossner, S; Hellstrom, PM
      Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

      INTERNATIONAL JOURNAL OF OBESITY
    71. Klausen, B; Toubro, S; Ranneries, C; Rehfeld, JF; Holst, JJ; Christensen, NJ; Astrup, A
      Increased intensity of a single exercise bout stimulates subsequent fat intake

      INTERNATIONAL JOURNAL OF OBESITY
    72. Henriksen, JH; Holst, JJ; Moller, S; Brinch, K; Bendtsen, F
      Increased circulating leptin in alcoholic cirrhosis: Relation to release and disposal

      HEPATOLOGY
    73. Wojdemann, M; Riber, C; Bisgaard, T; Sternby, B; Larsen, S; Rehfeld, JF; Holst, JJ; Olsen, O
      Inhibition of human gastric lipase by intraduodenal fat involves glucagon-like peptide-1 and cholecystokinin

      REGULATORY PEPTIDES
    74. Olesen, M; Gudmand-Hoyer, E; Holst, JJ; Jorgensen, S
      Importance of colonic bacterial fermentation in short bowel patients - Small intestinal malabsorption of easily digestible carbohydrate

      DIGESTIVE DISEASES AND SCIENCES
    75. Schmidt, PT; Rickelt, LF; Holst, JJ
      Tachykinins stimulate release of peptide hormones (glucagon-like peptide-1) and paracrine (somatostatin) and neurotransmitter (vasoactive intestinal polypeptide) from porcine ileum through NK-1 receptors

      DIGESTIVE DISEASES AND SCIENCES
    76. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
      Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients

      DIABETES CARE
    77. Deacon, CF; Holst, JJ; Carr, RD
      Glucagon-like peptide-1: A basis for new approaches to the management of diabetes

      DRUGS OF TODAY
    78. Wojdemann, M; Wettergren, A; Hartmann, B; Hilsted, L; Holst, JJ
      Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    79. Thulesen, J; Hartmann, B; Nielsen, C; Holst, JJ; Poulsen, SS
      Diabetic intestinal growth adaptation and glucagon-like peptide 2 in the rat: effects of dietary fibre

      GUT
    80. Schmidt, PT; Eriksen, L; Loftager, M; Rasmussen, TN; Holst, JJ
      Fast acting nervous regulation of immunoglobulin A secretion from isolatedperfused porcine ileum

      GUT
    81. Jeppesen, PB; Hartmann, B; Hansen, BS; Thulesen, J; Holst, JJ; Mortensen, PB
      Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure

      GUT
    82. Jensen, PB; Kristensen, P; Clausen, JT; Judge, ME; Hastrup, S; Thim, L; Wulff, BS; Foged, C; Jensen, J; Holst, JJ; Madsen, OD
      The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans

      FEBS LETTERS
    83. Bokvist, K; Hoy, M; Buschard, K; Holst, JJ; Thomsen, MK; Gromada, J
      Selectivity of prandial glucose regulators: nateglinide, but not repaglinide, accelerates exocytosis in rat pancreatic A-cells

      EUROPEAN JOURNAL OF PHARMACOLOGY
    84. Hansen, L; Deacon, CF; Orskov, C; Holst, JJ
      Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying theL cells of the porcine intestine

      ENDOCRINOLOGY
    85. Damholt, AB; Buchan, AMJ; Holst, JJ; Kofod, H
      Proglucagon processing profile in canine L cells expressing endogenous prohormone convertase 1/3 and prohormone convertase 2

      ENDOCRINOLOGY
    86. Nyholm, B; Walker, M; Gravholt, CH; Shearing, PA; Sturis, J; Alberti, KGMM; Holst, JJ; Schmitz, O
      Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations

      DIABETOLOGIA
    87. Balkan, B; Kwasnik, L; Miserendino, R; Holst, JJ; Li, X
      Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats

      DIABETOLOGIA
    88. Thomsen, C; Rasmussen, O; Lousen, T; Holst, JJ; Fenselau, S; Schrezenmeir, J; Hermansen, K
      Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects

      AMERICAN JOURNAL OF CLINICAL NUTRITION
    89. Schmidt, PT; Rasmussen, TN; Holst, JJ
      Tachykinins stimulate acid and pepsinogen secretion in the isolated porcine stomach

      ACTA PHYSIOLOGICA SCANDINAVICA
    90. NASLUND E; BACKMAN L; HOLST JJ; THEODORSSON E; HELLSTROM PM
      IMPORTANCE OF SMALL-BOWEL PEPTIDES FOR THE IMPROVED GLUCOSE-METABOLISM 20 YEARS AFTER JEJUNOILEAL BYPASS FOR OBESITY

      Obesity surgery
    91. WILLMS B; IDOWU K; HOLST JJ; CREUTZFELDT W; NAUCK MA
      OVERNIGHT GLP-1 NORMALIZES FASTING BUT NOT DAYTIME PLASMA-GLUCOSE LEVELS IN NIDDM PATIENTS

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    92. RASMUSSEN TN; BERSANI M; SCHMIDT P; THIM L; KOFOD H; JORGENSEN PN; POULSEN SS; HOLST JJ
      ISOLATION AND MOLECULAR CHARACTERIZATION OF PORCINE CALCITONIN-GENE-RELATED PEPTIDE (CGRP) AND ITS ENDOCRINE EFFECTS IN THE PORCINE PANCREAS

      Pancreas
    93. SVARTBERG J; HOLST JJ; GUTNIAK M; ADNER N
      THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)

      Pancreas
    94. SEIFARTH C; BERGMANN J; HOLST JJ; RITZEL R; SCHMIEGEL W; NAUCK MA
      PROLONGED AND ENHANCED SECRETION OF GLUCAGON-LIKE PEPTIDE-1 (7-36 AMIDE) AFTER ORAL SUCROSE DUE TO ALPHA-GLUCOSIDASE INHIBITION (ACARBOSE) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    95. NAUCK MA; WEBER I; BACH I; RICHTER S; ORSKOV C; HOLST JJ; SCHMIEGEL W
      NORMALIZATION OF FASTING GLYCEMIA BY INTRAVENOUS GLP-1 ([7-36 AMIDE] OR [7-37]) IN TYPE-2 DIABETIC-PATIENTS

      Diabetic medicine
    96. Zimmermann-Belsing, T; Dreyer, M; Holst, JJ; Feldt-Rasmussen, U
      The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects

      CLINICAL ENDOCRINOLOGY
    97. WETTERGREN A; WOJDEMANN M; HOLST JJ
      THE INHIBITORY EFFECT OF GLUCAGON-LIKE PEPTIDE-1 (7-36)AMIDE ON ANTRAL MOTILITY IS ANTAGONIZED BY ITS N-TERMINALLY TRUNCATED PRIMARY METABOLITE GLP-1 (9-36)AMIDE

      Peptides (New York, N.Y. 1980)
    98. WETTERGREN A; WOJDEMANN M; HOLST JJ
      GLUCAGON-LIKE PEPTIDE-1 INHIBITS GASTROPANCREATIC FUNCTION BY INHIBITING CENTRAL PARASYMPATHETIC OUTFLOW

      American journal of physiology: Gastrointestinal and liver physiology
    99. WETTERGREN A; PRIDAL L; WOJDEMANN M; HOLST JJ
      AMIDATED AND NON-AMIDATED GLUCAGON-LIKE PEPTIDE-1 (GLP-1) - NONPANCREATIC EFFECTS (CEPHALIC PHASE ACID-SECRETION) AND STABILITY IN PLASMA IN HUMANS

      Regulatory peptides
    100. NASLUND E; GRYBACK P; BACKMAN L; JACOBSSON H; HOLST JJ; THEODORSSON E; HELLSTROM PM
      DISTAL SMALL-BOWEL HORMONES - CORRELATION WITH FASTING ANTRODUODENAL MOTILITY AND GASTRIC-EMPTYING

      Digestive diseases and sciences


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 01:20:49